FFCP PHASE2:Hg19::chr4:103790120..103790186,+
From FANTOM5_SSTAR
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
| Short description: | p1@CISD2 |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_1_at_CISD2_5end |
| Coexpression cluster: | NA |
| Association with transcript: | 0bp_to_ENST00000273986, NM_001008388, uc003hwt.3_5end |
| EntrezGene: | CISD2 |
| HGNC: | 24212 |
| UniProt: | Q8N5K1 |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p1@CISD2 |
|---|
0
50
100
150
200
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| cancer | 8.99e-16 | 235 |
| disease of cellular proliferation | 4.98e-14 | 239 |
| organ system cancer | 9.67e-14 | 137 |
| hematologic cancer | 5.83e-13 | 51 |
| immune system cancer | 5.83e-13 | 51 |
| leukemia | 1.06e-10 | 39 |
| myeloid leukemia | 2.83e-09 | 31 |
Showing 1 to 7 of 7 entries
